Načítá se...
High Density Lipoprotein (HDL) Cholesterol: Leveraging Practice-Based Biobank Cohorts to Characterize Clinical and Genetic Predictors of Treatment Outcome
Over the past decade, large multicenter trials have unequivocally demonstrated that decreasing low density lipoprotein (LDL) cholesterol can reduce both primary and secondary cardiovascular events in patients at risk. However, even in the context of maximal LDL lowering, there remains considerable r...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3309611/ https://ncbi.nlm.nih.gov/pubmed/21151197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2010.86 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|